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Surgical TechniquesMiddle and posterior cardiac veins: An underused option for
ventricular pacingHenry M. Spotnitz, MD,a and Daniel Y. Wang, MD,b New York, NYThe middle and posterior cardiac veins are an alternative to
the coronary sinus for left ventricular lead insertion, one
that is well recognized by advocates of cardiac resynchroni-
zation therapy.1 These veins have not, however, been well
described as a realistic alternative to thoracotomy for
patients in whom leads cannot be passed across the tricuspid
annulus.2,3 This communication describes 2 cases in which
the posterior endocardial approach was used successfully,
thus avoiding possible morbidity related to repeated
thoracotomy in patients with complex disease and
multiple previous cardiac operations.CLINICAL SUMMARIES
Patient 1
A 31-year-old man with sinoatrial node dysfunction and
third-degree heart block was referred for epicardial pace-
maker insertion. The patient had previously undergone
closure of atrial and ventricular septal defects as well as
a maze procedure. Pulmonary and tricuspid valve replace-
ments had each been done twice, most recently with a me-
chanical tricuspid valve. Both pleural spaces had been
entered, and the patient had undergone reoperation for
bleeding on at least 1 occasion. His history was otherwise
notable for possible vonWillebrand disease. He had antico-
agulation with warfarin sodium (INN warfarin), a regimen
that was converted to unfractionated heparin before the
procedure. On clinical grounds, a transvenous approach
was attempted initially. Venous access was achieved by left
cephalic cutdown, and a Guidant Fineline II model 4471 pos-
itive fixation bipolar lead (Boston Scientific Corporation,
Natick, Mass) was passed centrally through the innominateFrom the Departments of Surgerya and Medicine,b Columbia University, New York,
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The Journal of Thoracic and Carvein. A posterior vein was directly cannulated without
a sheath, and the lead was passed distally as far as possible.
The pacing threshold was 2.5 V at a pulse width of 0.5 mil-
liseconds, an impedance of 1180 U, and an R wave of 12.0
mV. There was an early increase in the pacing threshold,
but at 6 months of follow-up the system was working well,
with a ventricular pacing threshold of 2.3 V (Figure 1).Patient 2
A 49-year-old woman was referred from an outside
hospital for treatment of congestive heart failure with severe
pulmonary hypertension. She had previously undergone
5 heart operations, including tricuspid valve replacement
with a bioprosthesis on 3 occasions and an epicardial biven-
tricular pacing system for heart block, supraventricular
tachycardia, and heart failure. Details of the previous
pacing systems were not available. The patient reported
that her symptoms had worsened since her last heart opera-
tion, and her pacemaker was not functioning well. Problems
included marked exit block on both leads and an exacerba-
tion of congestive heart failure. Clinically, it was difficult to
be certain whether the patient’s heart failure reflected
progressive tricuspid valve dysfunction or the loss of effec-
tive biventricular pacing. The patient’s right ventricular
systolic function, as assessed by 2-dimensional echocardi-
ography, was severely reduced. She had anticoagulation
with warfarin sodium, a regimen that was converted to
enoxaparin sodium (INN enoxaparin), and was referred
for epicardial lead revision. Tricuspid valvuloplasty was
being considered, making the standard endocardial lead
insertion unacceptable. We proposed endocardial coronary
sinus lead insertion, tunneling the new lead to her abdomi-
nal pocket. Venous access was obtained initially through
a left cephalic cutdown and subsequently by left subclavian
puncture. The orifice of the coronary sinus was cannulated
with a preformed coronary sinus cannula; however, there
were no suitable lateral branches for pacing located on the
venogram. A suitable site was finally located in a posterior
vein, where the thresholds were low and diaphragmatic
pacing could be avoided. The lead used was an 88-cm
Medtronic bipolar over-the-wire left heart lead (model
4194; Medtronic, Inc, Minneapolis, Minn). The pacing
threshold was 0.6 V at a pulse width of 0.5 milliseconds,
an impedance of 851 U, and an R wave of 26.8 mV. The
highest threshold epicardial lead was capped, and the
remaining ventricular lead (threshold 5.3 V) was connecteddiovascular Surgery c Volume 143, Number 5 1223
FIGURE 1. Posteroanterior (A) and lateral (B) radiographs of patient 1 with DDD pacemaker, including ventricular pacingwith a bipolar lead in a posterior
cardiac vein. This patient had previously undergone 3 cardiac operations, including tricuspid valve replacement with a mechanical prosthesis.
Surgical Techniquesto the right ventricular lead port of the generator with a small
safety margin to prolong battery life. The patient has
done well during the ensuing year. The thresholds on the
posterior lead remain at 1 V, her congestive heart failure
has improved, and right ventricular systolic function has
normalized according to echocardiography (Figure 2).
DISCUSSION
Coronary sinus lead insertion as an alternative to thoracot-
omy for permanent pacing has been reported in previous
case series,4 but the use of posterior veins is less well de-
scribed.2,3 Posterior veins are easier to access than the true
coronary sinus and its lateral branches, which require
acute cephalad angulation at the orifice. Among the
risks of the endocardial approach in the presence of
a mechanical tricuspid prosthesis is possible mechanical
lead entrapment, a serious complication if the lead cannot
be withdrawn. The small risk of entrapment must therefore
be weighed against the risks of reoperative thoracotomy.
Prosthetic lead rings project above the tricuspid annulus
into the right atrium, tending to deflect an advancing lead
peripherally toward the coronary sinus orifice. Other novelFIGURE 2. Posteroanterior (A) and lateral (B) radiographs of patient 2 with b
a posterior or middle cardiac vein. This patient had previously undergone 5 cardi
1224 The Journal of Thoracic and Cardiovascular Surapproaches to pacing access used to avoid formal
thoracotomy include right parasternal mediastinotomy,
transhepatic insertion, robotic approaches, and limited
thoracotomy with special screw-in lead applicators. Con-
cern exists that coronary sinus lead insertion could lead to
thrombosis of the coronary sinus, but this is apparently
rare.1 The fact that both patients had undergone previous
thoracotomy provided some security if the fixed screw op-
tion was needed, as in the case of patient 1. Lead advance-
ment was also done without previous venography in the
first case. Venography, customized insertion sheaths, and
over-the-wire techniques can greatly facilitate coronary si-
nus lead insertion and are the current state of the art for pri-
mary coronary sinus lead insertion.
The radiographs presented here do not clearly demon-
strate whether the caudal leads used are in the middle
cardiac (posterior interventricular) vein or in a posterior
left ventricular vein. The middle cardiac vein originates
close to the orifice of the coronary sinus and follows the
posterior interventricular groove toward the apex, whereas
posterior veins originate on the posterior aspect of the left
ventricle and drain into the coronary sinus further fromiventricular pacemaker, including ventricular pacing with a bipolar lead in
ac operations, including 3 tricuspid valve replacements with a bioprosthesis.
gery c May 2012
Surgical Techniquesthe orifice.5 Posterior veins are also referred to as inferolat-
eral collaterals and left posterior veins. The coronary sinus
venograms obtained during the treatment of patient 2 were
not preserved. Echocardiograms demonstrate the lead
entering the coronary sinus but do not define the final
venous location. It is likely that the vein used in the treat-
ment of patient 1 was a posterior vein, whereas the vein
used in the treatment of patient 2 was a posterior or middle
cardiac vein. Because the primary objective of lead inser-
tion in these patients was ventricular pacing and not cardiac
resynchronization therapy, the precise location of the veins
involved is primarily of academic interest.CONCLUSIONS
The middle and posterior cardiac veins provide access for
ventricular pacing as an alternative to thoracotomy when
passing a lead across the tricuspid annulus is contraindicated.From the Department of Cardiothoracic Surgery and Cardiology, St George’s
Hospital, University of London, London, United Kingdom.
Disclosures: Authors have nothing to disclose with regard to commercial support.
Received for publication Sept 14, 2011; revisions received Oct 20, 2011; accepted for
publication Oct 31, 2011; available ahead of print Dec 12, 2011.
Address for reprints: Marjan Jahangiri, FRCS (CTh), Department of Cardiothoracic
Surgery, St George’s Hospital, Blackshaw Rd, London SW17 0QT, United King-
dom (E-mail: Marjan.Jahangiri@stgeorges.nhs.uk).
J Thorac Cardiovasc Surg 2012;143:1225-7
0022-5223/$36.00
Copyright  2012 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2011.10.082
The Journal of Thoracic and CarAccess through these veins should be considered in patients
withcomplicatedsurgicalheart disease that includesahistory
of previous thoracotomy.References
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442-7.Early experience with the transaortic approach for transcatheter
aortic valve implantationGopal Soppa, MRCS, PhD, David Roy, MD, Stephen Brecker, FRCP, and Marjan Jahangiri, FRCS (CTh),
London, United KingdomTranscatheter aortic valve implantation (TAVI) for the
treatment of severe aortic stenosis (AS) is an increasingly
viable option for patients at high risk or with contraindica-
tions for surgical aortic valve replacement (SAVR).1 TAVI
improves survival and quality of life in high-risk patients
with severe AS compared with medical therapy and is
comparable with SAVR.1 The transfemoral (TF) approach
is the most common access route for deploying balloon-
expandable valves. Alternative access routes in patients
with severe peripheral vasculopathy include the transapi-
cal (TA),2 transaxillary (TAx), and, recently, the trans-
aortic (TAo) approaches.3 We describe our early
experience with the TAo approach.CLINICAL SUMMARY
Between February and August 2011, 12 patients under-
went TAVI with the TAo approach. Patients at high risk
for SAVR are referred to a multidisciplinary meeting, where
some will be scheduled to undergo surgical intervention,
TAVI, or only medical treatment.4 Our method of approach
for TAVI in the last 3 years has been primarily the TF
approach or, if this is not possible, the TAx or TA
approaches. However, because of the well-established min-
imally invasive SAVR procedure through a limited sternot-
omy5 in our unit and some of the complications associated
with the TF approach, as well as the unsuitability of some
patients for a peripheral approach, we started using the
TAo technique.
After achievement of general anesthesia, a temporary
pacing wire is placed through the internal jugular vein.
A limited J-sternotomy into the third intercostal space is
sufficient because access to the right atrium is not required.
The proximal aorta is exposed, and a ‘‘soft’’ point for aortic
puncture is identified by means of palpation and use of
a metal marker under fluoroscopic guidance (Figure 1, A).
This point is at least 6 cm above and in direct line with
the aortic valve (AV; Figure 1, B). Two purse-string sutures
with Teflon pledgets are placed, and aortic puncture is
performed. After crossing the AV by using the Seldingerdiovascular Surgery c Volume 143, Number 5 1225
